Category Archives: Science Policy

Ecuadorean Government Accuses Harvard Medical School Researchers and Others of Biopiracy

A public ombudsman in Ecuador has accused researchers at the Harvard Medical School, the Coriell Institute for Medical Research of Camden, New Jersey, and Maxus Energy Corporation of unlawfully acquiring and/or selling human DNA from members of the Waorani indigenous … Continue reading

Print Friendly
Posted in Biotechnology Law, Intellectual Property Law, Science Policy | Leave a comment

Thai Plant Variety Regulation on Hold as Plant Breeders Object to Access and Benefit Sharing Provisions

SciDevNet reports that Thai officials have suspended a regulation requiring plant breeders to obtain government permission before using wild plant varieties and certain domesticated varieties in the production of commercial plant varieties, and to share with the government the benefits … Continue reading

Print Friendly
Posted in Agricultural Law, Intellectual Property Law, Science Policy | Leave a comment

Will Nagoya Protocol on Access & Benefit Sharing Affect U.S. Drug Development?

A current article in Genetic Engineering & Biotechnology News considers the potential implications for pharmaceutical development of a new international agreement regarding access to, and sharing of benefits from, genetic resources. See Nagoya Protocol’s Rules for Genetic Resources Pose Challenges … Continue reading

Print Friendly
Posted in Intellectual Property Law, Science Policy | Leave a comment

U.S. Dept. of Health & Human Services Tightens Financial Conflict of Interest Rules for Researchers

On August 23, 2011, the U.S. Department of Health and Human Services (“HHS”) issued an updated Final Rule on conflict of interest, providing a framework for identifying, managing, and avoiding investigators’ financial conflicts of interest. See HHS, Responsibility of Applicants … Continue reading

Print Friendly
Posted in Science Policy | Leave a comment